Clinical Trials Directory

Trials / Completed

CompletedNCT03807466

Feedback to Improve Rational Strategies of Antibiotic Initiation and Duration in Long Term Care

Feedback to Improve Rational Strategies of Antibiotic Initiation and Duration in Long Term

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
356 (actual)
Sponsor
Institute for Clinical Evaluative Sciences · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

There is a high rate of inappropriate antibiotic use in long-term care (LTC) facilities, with both unnecessary initiation and prolongation of treatments. Although there are challenges to rational antibiotic use in LTC, the variability in antibiotic initiation and use of prolonged treatment durations is driven by prescriber tendencies rather than resident characteristics. Audit-and-feedback is a well-established intervention to improve professional practices, and is ideally suited for use to improve antibiotic prescribing tendencies in LTC. The literature is saturated with trials indicating benefit of audit-and-feedback, but is in dire need of studies to identify methods to improve the impact of this technique. Health Quality Ontario (HQO), a key partner in the FIRST AID-LTC research program, is already providing audit-and-feedback for other inappropriate prescribing practices in LTC, and has identified antibiotic prescribing as a priority focus.

Detailed description

Overarching Goals The overarching goals of FIRST AID - LTC are two-fold: 1. Improve rational antibiotic prescribing by physicians to minimize harms among LTC residents. 2. Advance the science of audit-and-feedback to improve physician prescribing practices. Specific Aims To improve rational antibiotic prescribing in LTC: 1. by decreasing unnecessary initiation of antibiotic treatments among Ontario LTC residents, as well as the variability in initiation rates across LTC prescribers. 2. by decreasing unnecessary prolonged duration of antibiotic treatments among Ontario LTC residents, as well as the variability in prolonged duration treatment use across LTC prescribers. To advance audit-and-feedback implementation science: 1\. by evaluating whether a dynamic audit-and-feedback report highlighting antibiotic prescribing can lead to greater reductions in antibiotic use, than a static paginated report Anticipated Contributions to Health-Related Knowledge Although the literature is inundated with trials examining the impact of audit-and-feedback compared to usual care, there is a need for studies to improve audit-and-feedback delivery. FIRST AID-LTC will test optimal delivery and peer comparison techniques for audit-and-feedback. The knowledge learned can be extrapolated to antibiotic interventions in LTC in other provinces across Canada, as well more broadly to inappropriate medication prescribing practices in LTC. Anticipated Contributions to Health Care, Health Systems and Health Outcomes FIRST AID-LTC will lead to immediate reductions in excess antibiotic use in Ontario LTC facilities, which in turn should result in substantial reductions in direct drug costs, as well as downstream complications of allergy, organ toxicity, C. difficile infections and antimicrobial resistance. With easy transferability to other Canadian provinces, the improvements in cost-savings and patient outcomes could be massive in scope.

Conditions

Interventions

TypeNameDescription
BEHAVIORALDynamic/Interactive vs. Static/Paginated ReportEvaluate whether a stand-alone interactive audit-and-feedback report highlighting antibiotic prescribing can lead to greater reductions in antibiotic use, than a report embedded in a broader static feedback system
BEHAVIORALLTC Physicians Enrolled vs. Not Enrolled in ReportsEvaluate whether being provided an audit-and-feedback report (regardless of dynamic or static) can lead to greater reductions in antibiotic use, than those who do not receive either report

Timeline

Start date
2017-05-15
Primary completion
2020-04-30
Completion
2021-03-31
First posted
2019-01-17
Last updated
2021-08-25

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT03807466. Inclusion in this directory is not an endorsement.